Competing interests
This study was funded by Novartis Services Inc. DR: honoraria from Novartis (including medical writing support for this current publication), Incyte, and Pfizer. CB: Speakers Bureau for Novartis, Janssen, and Pint Pharma; Board of Directors or advisory committees for Novartis and Janssen. MJM: personal fees from Bristol Myers Squibb, Takeda, and Pfizer. YM: honoraria from Novartis, BMS, Pfizer, and Astellas. AA, DD’A, and YW: employees of Novartis and holders of Novartis stock/shares. VKM: employee of Novartis at the time of conduct of this study. RL: employee of Adelphi Values, a consulting firm that received funding from Novartis to produce this work. SN and GS: Novartis advisory board and steering committee members. AH: research funding from Novartis, Bristol Myers Squibb, Pfizer, and Incyte.